BEIJING BETTA PHARMACEUTICALS CO LTD has a total of 15 patent applications. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), South Africa and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CENERX BIOPHARMA INC, GUDMUNDSSON KRISTJAN and AYUMI PHARMACEUTICAL CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | South Africa | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | Israel | 2 | |
#6 | Republic of Korea | 2 | |
#7 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Hu Yunyan | 13 |
#2 | Kang Xinshan | 13 |
#3 | Wang Yinxiang | 13 |
#4 | Long Wei | 13 |
#5 | Wang Yanping | 7 |
#6 | Ma Cunbo | 7 |
#7 | Cao Hong | 7 |
#8 | Tan Fenlai | 7 |
#9 | Zhang Jianxi | 5 |
#10 | Wang Fei | 5 |
Publication | Filing date | Title |
---|---|---|
KR20140076549A | Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof | |
EP2734504A1 | Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof |